| ACS | Acute Coronary Syndrome |
| AHA | American Heart Association |
| CAD | Coronary Artery Disease |
| CANTOS | Canakinumab Anti-Inflammatory Thrombosis Outcome Study |
| CI | Confidence Interval |
| COLCOT | Colchicine Cardiovascular Outcomes Trial |
| COLOCT | Colchicine–Optical Coherence Tomography Trial |
| COPS | Colchicine in Patients with Acute Coronary Syndrome Trial |
| CVD | Cardiovascular Disease |
| ESC | European Society of Cardiology |
| HR | Hazard Ratio |
| hsCRP | High Sensitivity C-Reactive Protein |
| LDL-C | Low-Density Lipoprotein Cholesterol |
| LoDoCo2 | Low-Dose Colchicine Randomised Controlled Trial |
| MACE | Major Adverse Cardiovascular Events |
| NSTEMI | Non-ST Elevation Myocardial Infarction |
| OR | Odds Ratio |
| PAV | Percent Atheroma Volume |
| PCI | Percutaneous Coronary Intervention |
| RCT | Randomised Controlled Trial |
| STEMI | ST Elevation Myocardial Infarction |
| TIA | Transient Ischaemic Attack |